Latest On Fresenius Medical Care AG & Co. KGaA (FMS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-05-17 05:58 EST | Dividend | A dividend of $0.63 has been announced on Apr 15, 2024. It will be paid Jun 3, 2024 with an ex-dividend date of May 17, 2024. | Neutral |  |
| 2023-05-26 04:49 EST | News | Fresenius sees brighter days for pharma division Kabi | N/A | |
| 2023-05-17 05:57 EST | Dividend | A dividend of $0.62 has been announced on May 3, 2023. It will be paid Jun 1, 2023 with an ex-dividend date of May 17, 2023. | Neutral | |
| 2023-05-09 21:01 EST | News | Fresenius Medical Care AG & Co. KGaA (FMS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 06:47 EST | News | Fresenius Q1 operating income drop softened by easing labor shortage; deconsolidation on track | N/A | |
| 2023-03-21 13:10 EST | News | Fresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' Rating | N/A | |
| 2023-02-22 20:16 EST | News | Fresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-22 20:16 EST | News | Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-22 07:16 EST | News | Fresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23 | N/A | |
| 2023-02-21 18:45 EST | News | Fresenius Medical Care Q4 2022 Earnings Preview | N/A | |
| 2023-02-09 18:36 EST | News | Fresenius considering deconsolidating dialysis subsidiary - Bloomberg | N/A | |
| 2023-01-06 19:18 EST | News | Fresenius: The Company Is Climbing, And I'm At 'Buy' | N/A | |
| 2022-12-06 11:18 EST | News | Fresenius Medical Care CFO takes over as CEO amid focus on 'operational turnaround' | N/A | |
| 2022-11-01 02:52 EST | News | Fresenius under pressure to make changes as activist Elliott takes 3% stake - Bloomberg | N/A | |
| 2022-11-01 02:52 EST | News | Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-10-31 10:36 EST | News | Fresenius Q3 net income falls amid labor market woes, cuts FY22 outlook on slower recovery | N/A | |
| 2022-10-31 10:35 EST | News | Fresenius Medical Care AG & Co. KGaA 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-10-27 18:07 EST | News | Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis) | N/A | |
| 2022-10-19 18:05 EST | News | Fresenius Medical gains after report of activist Elliott stake in Fresenius SE | N/A | |
| 2022-10-10 19:51 EST | News | Fresenius cut to Hold at Jefferies citing staffing issues and inflation | N/A | |
| 2022-08-31 05:50 EST | News | Fresenius gets award to provide dialysis services to U.S. military veterans | N/A | |
| 2022-08-21 01:47 EST | News | Fresenius appoints head of pharma unit as new CEO | N/A | |
| 2022-08-19 05:43 EST | News | Fresenius: Too Cheap, Measured By Sum-Of-The-Parts | N/A | |
| 2022-07-30 11:07 EST | News | Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat | N/A | |
| 2022-07-28 17:20 EST | News | Fresenius stock slumps 13% as labor costs, inflation impact leads to FY22 outlook cut; 2025 targets withdrawn | N/A | |
| 2022-07-14 00:09 EST | News | Fresenius slips as U.S. joins whistleblower lawsuit over Medicare fraud | N/A | |
| 2022-06-19 10:01 EST | News | Fresenius: Revisiting The Thesis - Still A Buy | N/A | |
| 2022-05-13 05:58 EST | Dividend | A dividend of $0.71 has been announced on Apr 28, 2022. It will be paid May 27, 2022 with an ex-dividend date of May 13, 2022. | Neutral | |
| 2022-05-04 16:46 EST | News | Fresenius Medical Care Non-GAAP EPS of €0.68, revenue of €4.55B | N/A | |
| 2022-05-04 16:46 EST | News | Fresenius Medical Care AG & Co. (FMS) CEO Rice Powell on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 00:06 EST | News | Fresenius Medical names Carla Kriwet as next CEO | N/A | |
| 2022-05-02 12:10 EST | News | Fresenius: The Upside Is Getting Bigger | N/A | |
| 2022-03-31 22:53 EST | News | Fresenius Kabi bolsters biosimilar, infusion businesses with mAbxience and Ivenix deals | N/A | |
| 2022-02-23 09:19 EST | News | Fresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-22 14:15 EST | News | Fresenius Medical Care Non-GAAP EPS of €0.90, revenue of €4.64B | N/A | |
| 2022-02-09 23:34 EST | News | Fresenius Medical Care: World Leader In Dialysis, But Still Not Exciting | N/A | |
| 2021-12-01 13:22 EST | News | Fresenius Medical Care announces company reorganization | N/A | |
| 2021-11-08 23:21 EST | News | Fresenius Medical Care reports Q3 results | N/A | |
| 2021-11-03 03:44 EST | News | Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-22 13:49 EST | News | Fresenius Medical Care partners with JMS to advance home dialysis in Japan | N/A | |
| 2021-09-10 12:19 EST | News | Fresenius Medical Care stock falls ~4% amid JPMorgan downgrade on COVID impact | N/A | |
| 2021-08-28 14:57 EST | News | You Really Want To Know About Fresenius Medical Care | N/A | |
| 2021-07-31 01:01 EST | News | Fresenius Medical Care AG & Co. KGaA 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-07-31 01:00 EST | News | Fresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-30 05:41 EST | News | Fresenius Medical Care misses on revenue | N/A | |
| 2021-05-24 05:59 EST | Dividend | A dividend of $0.83 has been announced on Nov 30, -0001. It will be paid Jun 7, 2021 with an ex-dividend date of May 24, 2021. | Neutral | |
| 2021-03-18 23:24 EST | Analyst Rating | The Analyst Target Price has increased from $37.49 to $37.74. | Buy | |
| 2021-03-17 22:28 EST | Analyst Rating | The Analyst Target Price has decreased from $37.56 to $37.49. | Neutral | |
| 2021-03-17 14:31 EST | Analyst Rating | The Analyst Target Price has decreased from $37.65 to $37.56. | Neutral | |
| 2021-03-17 13:39 EST | News | Fresenius Medical Care Appears To Be Fairly Valued | N/A | |
About Fresenius Medical Care AG & Co. KGaA (FMS):
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
General
- Name Fresenius Medical Care AG & Co. KGaA
- Symbol FMS
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Care Facilities
- Full Time Employees 125,364
- Last Split Factor2:1
- Last Split Date2012-12-04
- Fiscal Year EndDecember
- IPO Date1996-09-19
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Gic SubIndustryHealth Care Services
- Web URLhttp://www.freseniusmedicalcare.com
View More
Valuation
- Trailing PE 9.88
- Forward PE 13.18
- Price/Sales (Trailing 12 Mt.) 1.01
- Price/Book (Most Recent Quarter) 1.6
- Enterprise Value Revenue 1.94
- Enterprise Value EBITDA 8.4
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $2.16
- Next Year EPS Estimate $2.40
- Next Quarter EPS Estimate $0.69
- Profit Margin 7%
- Return on Assets 5%
- Return on Equity 11%
- Earnings Per Share $3.69
- Revenue Per Share $0
- Gross Profit 5.54 billion
- Quarterly Earnings Growth -3.9%
View More
Highlights
- Market Capitalization 21.37 billion
- PEG Ratio 2.23
- Analyst Target Price $37.74
- Book Value Per Share $21.29
View More
Share Statistics
- Shares Outstanding 585.75 million
- Shares Float 396.99 million
- % Held by Insiders <1%
- % Held by Institutions 1.63%
- Shares Short 995926
- Shares Short Prior Month 360804
- Short Ratio 1.42
View More
Technicals
- Beta 0.96
- 52 Week High $45.78
- 52 Week Low $28.69
- 50 Day Moving Average 36.07
- 200 Day Moving Average 40.4
View More
Dividends
- Forward Annual Dividend Rate $0.72
- Forward Annual Dividend Yield 1.96%
- Payout Ratio 26%
- Dividend Date 2020-09-11
- ExDividend Date 2020-08-28
- Dividend Per Share $1.24
- Dividend Yield 2.89%
View More
Fresenius Medical Care AG & Co. KGaA (FMS) Dividend Calendar:
Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.72 per share, with a dividend yield of 2.89%.
FMS's last dividend payment was made to shareholders on September 11, 2020.
Fresenius Medical Care AG & Co. KGaA pays out 26% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-23 | $N/A | $0.77 | $0.80 | -3.85% |
| 2020-09-30 | 2020-10-29 | $4.41 billion | $0.71 | $0.64 | 11.1% |
| 2020-06-30 | 2020-07-30 | $4.56 billion | $0.71 | $0.54 | 31.36% |
| 2020-03-31 | 2020-05-06 | $N/A | $0.51 | $0.63 | -18.4% |
| 2019-12-31 | 2020-02-20 | $5.14 billion | $0.73 | $0.69 | 6.67% |
| 2019-09-30 | 2019-10-29 | $4.82 billion | $0.61 | $0.61 | -0.52% |
| 2019-06-30 | 2019-07-30 | $4.9 billion | $0.51 | $0.55 | -6.36% |
| 2019-03-31 | 2019-05-02 | $4.63 billion | $0.58 | $0.51 | 14.34% |
| 2018-12-31 | 2019-02-20 | $4.93 billion | $0.65 | $0.65 | -0.14% |
| 2018-09-30 | 2018-10-30 | $4.7 billion | $0.57 | $0.64 | -10.2% |
| 2018-06-30 | 2018-07-31 | $4.9 billion | $0.52 | $0.62 | -16.54% |
| 2018-03-31 | 2018-05-03 | $4.89 billion | $0.48 | $0.61 | -21.61% |
| 2017-12-31 | 2018-02-26 | $5.6 billion | $0.73 | $0.66 | 10.21% |
| 2017-09-30 | 2017-11-02 | $5.48 billion | $0.61 | $0.62 | -1.93% |
| 2017-06-30 | 2017-08-01 | $5.43 billion | $0.53 | $0.51 | 2.61% |
| 2017-03-31 | 2017-05-03 | $4.87 billion | $0.44 | $0.44 | 1.42% |
| 2016-12-31 | 2017-02-22 | $4.69 billion | $0.61 | $0.62 | -2.01% |
| 2016-09-30 | 2016-10-27 | $4.6 billion | $0.55 | $0.52 | 4.81% |
| 2016-06-30 | 2016-08-01 | $4.42 billion | $0.48 | $0.49 | -2.44% |
| 2016-03-31 | 2016-05-03 | $4.21 billion | $0.37 | $0.42 | -11.38% |
| 2015-12-31 | 2016-02-24 | $4.35 billion | $0.57 | $0.58 | -1.63% |
| 2015-09-30 | 2015-10-29 | $4.23 billion | $0.43 | $0.46 | -6.52% |
| 2015-06-30 | 2015-07-30 | $4.2 billion | $0.40 | $0.42 | -4.76% |
| 2015-03-31 | 2015-04-29 | $3.96 billion | $0.35 | $0.39 | -10.26% |
| 2014-12-31 | 2015-02-25 | $4.32 billion | $0.55 | $0.49 | 12.24% |
| 2014-09-30 | 2014-11-04 | $4.11 billion | $0.45 | $0.44 | 2.27% |
| 2014-06-30 | 2014-07-31 | $3.83 billion | $0.42 | $0.41 | 2.44% |
| 2014-03-31 | 2014-05-06 | $3.56 billion | $0.34 | $0.38 | -10.53% |
| 2013-12-31 | 2014-02-25 | $3.87 billion | $0.59 | $0.53 | 11.32% |
| 2013-09-30 | 2013-11-05 | $3.67 billion | $0.48 | $0.46 | 4.35% |
| 2013-06-30 | 2013-07-30 | $3.61 billion | $0.43 | $0.45 | -4.44% |
| 2013-03-31 | 2013-04-30 | $3.46 billion | $0.37 | $0.43 | -13.95% |
| 2012-12-31 | 2013-02-26 | $3.71 billion | $0.54 | $0.51 | 5.88% |
| 2012-09-30 | 2012-10-31 | $3.42 billion | $0.44 | $0.49 | -10.2% |
| 2012-06-30 | 2012-08-01 | $3.43 billion | $0.46 | $0.46 | 0% |
| 2012-03-31 | 2012-05-03 | $3.25 billion | $0.40 | $0.39 | 2.56% |
| 2011-12-31 | 2012-02-21 | $3.26 billion | $0.51 | $0.52 | -1.92% |
| 2011-09-30 | 2011-11-02 | $3.18 billion | $0.46 | $0.47 | -2.13% |
| 2011-06-30 | 2011-08-02 | $3.14 billion | $0.43 | $0.43 | 0% |
| 2011-03-31 | 2011-05-04 | $2.98 billion | $0.37 | $0.38 | -2.63% |
| 2010-12-31 | 2011-02-23 | $3.17 billion | $0.45 | $0.44 | 2.27% |
| 2010-09-30 | 2010-11-02 | $3.06 billion | $0.41 | $0.42 | -2.38% |
| 2010-06-30 | 2010-08-03 | $2.95 billion | $0.42 | $0.40 | 5% |
| 2010-03-31 | 2010-05-04 | $2.88 billion | $0.35 | $0.37 | -5.41% |
| 2009-12-31 | 2010-02-24 | $3.04 billion | $0.41 | $0.39 | 5.13% |
| 2009-09-30 | 2009-11-03 | $2.89 billion | $0.38 | $0.37 | 2.7% |
| 2009-06-30 | 2009-08-04 | $2.76 billion | $0.37 | $0.37 | 0% |
| 2009-03-31 | 2009-04-30 | $2.56 billion | $0.34 | $0.34 | 0% |
| 2008-12-31 | 2009-02-19 | $2.72 billion | $0.36 | $0.36 | 0% |
| 2008-09-30 | 2008-11-04 | $2.71 billion | $0.35 | $0.34 | 2.94% |
| 2008-06-30 | 2008-07-30 | $2.67 billion | $0.36 | $0.33 | 9.09% |
| 2008-03-31 | 2008-04-30 | $2.51 billion | $0.32 | $0.31 | 3.23% |
| 2007-12-31 | 2008-02-20 | $2.57 billion | $0.34 | $0.31 | 9.68% |
| 2007-09-30 | 2007-10-30 | $2.43 billion | $0.31 | $0.30 | 3.33% |
| 2007-06-30 | 2007-08-02 | $2.4 billion | $0.30 | $0.29 | 3.45% |
| 2007-03-31 | 2007-05-02 | $2.32 billion | $0.27 | $0.27 | 0% |
| 2006-12-31 | 2007-02-22 | $2.35 billion | $0.26 | $0.26 | 0% |
| 2006-09-30 | 2006-10-31 | $2.23 billion | $0.24 | $0.23 | 4.35% |
| 2006-06-30 | 2006-08-03 | $2.17 billion | $0.22 | $0.26 | -15.38% |
| 2006-03-31 | 2006-05-03 | $1.75 billion | $0.20 | $0.19 | 5.26% |
| 2005-12-31 | 2006-02-22 | $1.77 billion | $0.19 | ||
| 2005-09-30 | 2005-11-03 | $1.72 billion | $0.20 | $0.20 | 0% |
| 2005-06-30 | 2005-08-04 | $1.67 billion | $0.20 | $0.20 | 0% |
| 2005-03-31 | 2005-05-03 | $1.61 billion | $0.19 | $0.20 | -5% |
| 2004-12-31 | 2005-02-24 | $1.64 billion | $0.19 | $0.20 | -5% |
| 2004-09-30 | 2004-11-02 | $1.58 billion | $0.18 | $0.18 | -1.83% |
| 2004-06-30 | 2004-08-04 | $1.55 billion | $0.17 | ||
| 2004-03-31 | 2004-05-06 | $1.46 billion | $0.17 | ||
| 2003-12-31 | 2004-02-26 | $1.45 billion | $0.17 | ||
| 2003-09-30 | 2003-11-04 | $1.41 billion | $0.15 | ||
| 2003-06-30 | 2003-08-05 | $1.37 billion | $0.15 | ||
| 2003-03-31 | 2003-05-07 | $1.3 billion | $0.13 | ||
| 2002-12-31 | 2003-02-25 | $1.36 billion | $0.14 | $0.13 | 7.69% |
| 2002-09-30 | 2002-10-29 | $1.29 billion | $0.12 | $0.12 | 0% |
| 2002-06-30 | 2002-07-30 | $1.25 billion | $0.13 | $0.13 | 0% |
| 2002-03-31 | 2002-04-30 | $1.19 billion | $0.13 | $0.14 | -7.14% |
| 2001-12-31 | 2002-03-05 | $1.27 billion | $0.11 | $0.11 | 0% |
| 2001-09-30 | 2001-10-30 | $1.23 billion | $0.11 | $0.12 | -8.33% |
| 2001-06-30 | 2001-07-31 | $1.2 billion | $0.11 | $0.11 | 0% |
| 2001-03-31 | 2001-05-03 | $1.16 billion | $0.10 | $0.11 | -9.09% |
| 2000-12-31 | 2001-01-01 | $1.08 billion | $0.11 | $0.11 | 0% |
| 2000-09-30 | 2000-12-31 | $1.08 billion | $0.11 | $0.11 | 0% |
| 2000-06-30 | 2000-07-01 | $1.04 billion | $0.10 | $0.11 | -9.09% |
| 2000-03-31 | 2000-06-30 | $1 billion | $0.10 | $0.11 | -9.09% |
| 1999-09-30 | 1999-11-23 | $0.10 | $0.09 | 11.11% | |
| 1999-06-30 | 1999-08-03 | $0.09 | $0.08 | 12.5% | |
| 1999-03-31 | 1999-03-31 | $0.08 | |||
| 1998-12-31 | 1999-03-29 | $0.07 | $0.07 | 0% | |
| 1998-06-30 | 1998-07-23 | $0.04 | $0.06 | -33.33% | |
| 1997-09-30 | 1997-11-25 | $0.04 | $0.05 | -20% | |
| 1997-06-30 | 1997-08-27 | $0.07 | $0.07 | 0% | |
| 1997-03-31 | 1997-05-15 | $0.06 | $0.09 | -33.33% |
Fresenius Medical Care AG & Co. KGaA (FMS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Fresenius Medical Care AG & Co. KGaA (FMS) Chart:
Fresenius Medical Care AG & Co. KGaA (FMS) News:
Below you will find a list of latest news for Fresenius Medical Care AG & Co. KGaA (FMS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Fresenius Medical Care AG & Co. KGaA (FMS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 471.79 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 346.8 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 265.03 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | CALL | 0 | 0 | 178.65 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | CALL | 0 | 0 | 156.89 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 2.35 | CALL | 0 | 0 | 115.54 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 1.25 | CALL | 0 | 9 | 65.33 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0.3 | CALL | 0 | 55 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0.1 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0.15 | PUT | 0 | 62 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0.1 | PUT | 0 | 194 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0.35 | PUT | 74 | 132 | 41.05 | FALSE | 0.35 | 0 |
| 2024-06-21 | 22.5 | 1.1 | PUT | 0 | 34 | 30.2 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 44.04 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 105.62 | TRUE | 0 | 0 |
| 2024-06-21 | 35 | 0 | PUT | 0 | 0 | 123.75 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 13.7 | CALL | 0 | 0 | 266.46 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 0 | CALL | 0 | 0 | 196.3 | TRUE | 0 | 0 |
| 2024-07-19 | 12.5 | 0 | CALL | 0 | 0 | 150.54 | TRUE | 0 | 0 |
| 2024-07-19 | 15 | 6.5 | CALL | 0 | 0 | 122.79 | TRUE | 0 | 0 |
| 2024-07-19 | 17.5 | 4.7 | CALL | 1 | 28 | 51.23 | TRUE | 4.7 | 0 |
| 2024-07-19 | 20 | 2.55 | CALL | 1 | 81 | 40.85 | TRUE | 2.55 | 0 |
| 2024-07-19 | 22.5 | 1.05 | CALL | 1 | 362 | 36.5 | FALSE | 1.05 | 0 |
| 2024-07-19 | 25 | 0.45 | CALL | 0 | 90 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 30 | 0.1 | CALL | 0 | 36 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 10 | 0.15 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 12.5 | 0.15 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 0.1 | PUT | 1 | 15 | 57.62 | FALSE | 0.1 | 0 |
| 2024-07-19 | 17.5 | 0.25 | PUT | 1 | 63 | 48.3 | FALSE | 0.25 | 0 |
| 2024-07-19 | 20 | 0.6 | PUT | 1 | 46 | 39.23 | FALSE | 0.6 | 0 |
| 2024-07-19 | 22.5 | 1.5 | PUT | 1 | 83 | 32.69 | TRUE | 1.5 | 0 |
| 2024-07-19 | 25 | 0 | PUT | 0 | 0 | 34.25 | TRUE | 0 | 0 |
| 2024-07-19 | 30 | 0 | PUT | 0 | 0 | 74.49 | TRUE | 0 | 0 |
| 2024-07-19 | 35 | 0 | PUT | 0 | 0 | 103.56 | TRUE | 0 | 0 |
| 2024-10-18 | 10 | 0 | CALL | 0 | 0 | 142.89 | TRUE | 0 | 0 |
| 2024-10-18 | 12.5 | 0 | CALL | 0 | 0 | 109.88 | TRUE | 0 | 0 |
| 2024-10-18 | 15 | 4.5 | CALL | 0 | 1 | 89.04 | TRUE | 0 | 0 |
| 2024-10-18 | 17.5 | 2.7 | CALL | 0 | 27 | 59.09 | TRUE | 0 | 0 |
| 2024-10-18 | 20 | 2.75 | CALL | 0 | 113 | 52.62 | TRUE | 0 | 0 |
| 2024-10-18 | 22.5 | 0.75 | CALL | 0 | 169 | 45.38 | FALSE | 0 | 0 |
| 2024-10-18 | 25 | 0.8 | CALL | 0 | 12 | 34.54 | FALSE | 0 | 0 |
| 2024-10-18 | 30 | 0.35 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 10 | 0.35 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 12.5 | 0.3 | PUT | 0 | 126 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 15 | 0.68 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 17.5 | 1.5 | PUT | 0 | 21 | 42.37 | FALSE | 0 | 0 |
| 2024-10-18 | 20 | 2.75 | PUT | 0 | 194 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 22.5 | 4.3 | PUT | 0 | 5 | 30.65 | TRUE | 0 | 0 |
| 2024-10-18 | 25 | 6.4 | PUT | 0 | 1 | 32 | TRUE | 0 | 0 |
| 2024-10-18 | 30 | 10.5 | PUT | 0 | 1 | 52.81 | TRUE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | CALL | 0 | 0 | 77.28 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 0 | CALL | 0 | 0 | 67.41 | TRUE | 0 | 0 |
| 2025-01-17 | 17.5 | 0 | CALL | 0 | 0 | 55.36 | TRUE | 0 | 0 |
| 2025-01-17 | 20 | 0 | CALL | 0 | 0 | 49.32 | TRUE | 0 | 0 |
| 2025-01-17 | 22.5 | 0 | CALL | 0 | 0 | 48.48 | FALSE | 0 | 0 |
| 2025-01-17 | 25 | 0 | CALL | 0 | 0 | 42.62 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 22.5 | 0 | PUT | 0 | 0 | 29.02 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 0 | PUT | 0 | 0 | 29.12 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 0 | PUT | 0 | 0 | 29.4 | TRUE | 0 | 0 |
Latest FMS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 23 | $26.55 |
| Jun 13, 2022 7:59 PM EST | 13 | $26.565 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.585 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.585 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.585 |
Fresenius Medical Care AG & Co. KGaA (FMS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm |
| 2005-10-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1019600/000000000005053088/0000000000-05-053088-index.htm |
| 2006-02-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1019600/000000000006008760/0000000000-06-008760-index.htm |
| 2008-06-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1019600/000000000008027712/0000000000-08-027712-index.htm |
| 2008-06-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1019600/000000000008027713/0000000000-08-027713-index.htm |
| 2019-06-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1333141/000021545719008072/0000215457-19-008072-index.htm |
| 2011-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1019600/000031506611002522/0000315066-11-002522-index.htm |
| 2012-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1019600/000031506612002646/0000315066-12-002646-index.htm |
| 2005-10-07 | F-4 | Registration of securities, foreign private issuers, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000095012305011984/0000950123-05-011984-index.htm |
| 2005-10-11 | SC TO-I | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1019600/000095012305012031/0000950123-05-012031-index.htm |
| 2005-11-17 | F-4/A | Registration of securities, foreign private issuers, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000095012305013817/0000950123-05-013817-index.htm |
| 2005-11-17 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1019600/000095012305013818/0000950123-05-013818-index.htm |
| 2005-12-23 | F-4/A | Registration of securities, foreign private issuers, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000095012305015163/0000950123-05-015163-index.htm |
| 2005-12-23 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1019600/000095012305015166/0000950123-05-015166-index.htm |
| 2005-12-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1019600/000095012305015380/0000950123-05-015380-index.htm |
| 2006-01-04 | F-4/A | Registration of securities, foreign private issuers, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000027/0000950123-06-000027-index.htm |
| 2006-01-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000029/0000950123-06-000029-index.htm |
| 2006-01-06 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000130/0000950123-06-000130-index.htm |
| 2006-01-06 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000131/0000950123-06-000131-index.htm |
| 2006-01-26 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000714/0000950123-06-000714-index.htm |
| 2006-01-26 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1019600/000095012306000715/0000950123-06-000715-index.htm |
| 2006-02-09 | SC TO-I/A | Tender offer statement by Issuer | https://www.sec.gov/Archives/edgar/data/1019600/000095012306001370/0000950123-06-001370-index.htm |
| 2005-07-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605000791/0001019056-05-000791-index.htm |
| 2005-08-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605000840/0001019056-05-000840-index.htm |
| 2005-08-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605000931/0001019056-05-000931-index.htm |
| 2005-08-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605000958/0001019056-05-000958-index.htm |
| 2005-10-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001039/0001019056-05-001039-index.htm |
| 2005-11-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001105/0001019056-05-001105-index.htm |
| 2005-11-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001255/0001019056-05-001255-index.htm |
| 2005-12-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001259/0001019056-05-001259-index.htm |
| 2005-12-20 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001318/0001019056-05-001318-index.htm |
| 2005-12-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001326/0001019056-05-001326-index.htm |
| 2005-12-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905605001329/0001019056-05-001329-index.htm |
| 2006-01-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905606000002/0001019056-06-000002-index.htm |
| 2006-01-04 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1019600/000101905606000004/0001019056-06-000004-index.htm |
| 2006-02-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905606000078/0001019056-06-000078-index.htm |
| 2006-02-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905606000110/0001019056-06-000110-index.htm |
| 2006-02-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000101905606000133/0001019056-06-000133-index.htm |
| 2019-02-20 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/0001047469-19-000562-index.htm |
| 2019-05-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746919002820/0001047469-19-002820-index.htm |
| 2019-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746919004442/0001047469-19-004442-index.htm |
| 2019-10-31 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1333141/000104746919006012/0001047469-19-006012-index.htm |
| 2019-10-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746919006013/0001047469-19-006013-index.htm |
| 2020-02-20 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1333141/000104746920000960/0001047469-20-000960-index.htm |
| 2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746920002846/0001047469-20-002846-index.htm |
| 2020-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746920004330/0001047469-20-004330-index.htm |
| 2020-10-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000104746920005337/0001047469-20-005337-index.htm |
| 2019-02-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919009478/0001104659-19-009478-index.htm |
| 2019-02-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919009480/0001104659-19-009480-index.htm |
| 2019-02-20 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act | https://www.sec.gov/Archives/edgar/data/1333141/000110465919009524/0001104659-19-009524-index.htm |
| 2019-02-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919009728/0001104659-19-009728-index.htm |
| 2019-02-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919010540/0001104659-19-010540-index.htm |
| 2019-03-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919014180/0001104659-19-014180-index.htm |
| 2019-04-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919019519/0001104659-19-019519-index.htm |
| 2019-04-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919020567/0001104659-19-020567-index.htm |
| 2019-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919024995/0001104659-19-024995-index.htm |
| 2019-05-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919026308/0001104659-19-026308-index.htm |
| 2019-05-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919030697/0001104659-19-030697-index.htm |
| 2019-05-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919031908/0001104659-19-031908-index.htm |
| 2019-05-31 | SD | https://www.sec.gov/Archives/edgar/data/1333141/000110465919033034/0001104659-19-033034-index.htm | |
| 2019-06-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919035489/0001104659-19-035489-index.htm |
| 2019-06-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919036076/0001104659-19-036076-index.htm |
| 2019-06-27 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/1333141/000110465919037864/0001104659-19-037864-index.htm |
| 2019-07-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919039891/0001104659-19-039891-index.htm |
| 2019-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919042505/0001104659-19-042505-index.htm |
| 2019-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919047645/0001104659-19-047645-index.htm |
| 2019-10-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919057169/0001104659-19-057169-index.htm |
| 2019-10-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919057180/0001104659-19-057180-index.htm |
| 2019-10-31 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919058403/0001104659-19-058403-index.htm |
| 2019-10-31 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919058428/0001104659-19-058428-index.htm |
| 2019-11-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465919066019/0001104659-19-066019-index.htm |
| 2020-02-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920023065/0001104659-20-023065-index.htm |
| 2020-02-20 | IRANNOTICE | Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act | https://www.sec.gov/Archives/edgar/data/1333141/000110465920023280/0001104659-20-023280-index.htm |
| 2020-02-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920023628/0001104659-20-023628-index.htm |
| 2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920057373/0001104659-20-057373-index.htm |
| 2020-05-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920063458/0001104659-20-063458-index.htm |
| 2020-05-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920064025/0001104659-20-064025-index.htm |
| 2020-05-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920064587/0001104659-20-064587-index.htm |
| 2020-05-29 | SD | https://www.sec.gov/Archives/edgar/data/1333141/000110465920067320/0001104659-20-067320-index.htm | |
| 2020-06-26 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm |
| 2020-07-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920084339/0001104659-20-084339-index.htm |
| 2020-07-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920088067/0001104659-20-088067-index.htm |
| 2020-08-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920099294/0001104659-20-099294-index.htm |
| 2020-09-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920103698/0001104659-20-103698-index.htm |
| 2020-10-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920114053/0001104659-20-114053-index.htm |
| 2020-10-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1333141/000110465920119245/0001104659-20-119245-index.htm |
| 2005-08-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000132693205000058/0001326932-05-000058-index.htm |
| 2005-11-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000132693205000107/0001326932-05-000107-index.htm |
| 2006-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1019600/000132693206000162/0001326932-06-000162-index.htm |